http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 31 Aug 2026 09:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Elanco+Scales+Biologics+Capabilities+With+Expansion+of+Kansas+Manufacturing+Facility/27002295.html <p><i><strong>The completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipeline</strong></i></p> <p><strong id="dateline">INDIANAPOLIS, IN / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / August 31, 2026 / </strong>Elanco Animal Health Incorporated (NYSE:ELAN) announced the on-time completion of a 25,000-square-foot manufacturing expansion of its Elwood, Kansas manufacturing site. As one of only two animal health companies with mAb solutions on the market today, the expansion further strengthens Elanco's leadership in the biologics space.</p><p>"When we announced the expansion two years ago, we recognized that executing the most exciting pipeline in Elanco's history required a http://www.streetinsider.com/Press+Releases/Elanco+Scales+Biologics+Capabilities+With+Expansion+of+Kansas+Manufacturing+Facility/27002295.html Mon, 31 Aug 2026 09:30:00 -0400 ELAN http://www.streetinsider.com/ACCESS+Newswire/Elanco+Scales+Biologics+Capabilities+With+Expansion+of+Kansas+Manufacturing+Facility/27002295.html <p><i><strong>The completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipeline</strong></i></p> <p><strong id="dateline">INDIANAPOLIS, IN / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / August 31, 2026 / </strong>Elanco Animal Health Incorporated (NYSE:ELAN) announced the on-time completion of a 25,000-square-foot manufacturing expansion of its Elwood, Kansas manufacturing site. As one of only two animal health companies with mAb solutions on the market today, the expansion further strengthens Elanco's leadership in the biologics space.</p><p>"When we announced the expansion two years ago, we recognized that executing the most exciting pipeline in Elanco's history required a http://www.streetinsider.com/ACCESS+Newswire/Elanco+Scales+Biologics+Capabilities+With+Expansion+of+Kansas+Manufacturing+Facility/27002295.html Mon, 31 Aug 2026 09:30:00 -0400 ELAN http://www.streetinsider.com/Corporate+News/Elanco+completes+%24120M+Kansas+facility+expansion+for+mAb+production/26977771.html <p>Elanco Animal Health Incorporated (NYSE: ELAN) announced the completion of a 25,000-square-foot manufacturing expansion at its Elwood, Kansas facility, representing a $120 million investment aimed at increasing monoclonal antibody (mAb) production capacity.</p><p>The expansion increases the site's production capacity by more than four times through new upstream and downstream processing equipment. It also includes a new pilot plant for process development and clinical testing materials, a new quality control laboratory, and additional support spaces. Burns & McDonnell, a Kansas City, Mo.-based design-build firm, led the project. An additional $30 million investment is planned through 2028 for warehousing, bringing the total planned http://www.streetinsider.com/Corporate+News/Elanco+completes+%24120M+Kansas+facility+expansion+for+mAb+production/26977771.html Wed, 26 Aug 2026 08:31:36 -0400 ELAN http://www.streetinsider.com/Press+Releases/Elanco+Scales+Biologics+Capabilities+with+Expansion+of+Kansas+Manufacturing+Facility/26977733.html <div class="xn-content"> <p class="prntac"><b><i>The completed 25,000-square-foot <location value="LU/us.ks.elwood" idsrc="xmltag.org" >Elwood</location> site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipeline</i></b></p><p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>Aug. 26, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:ELAN" idsrc="xmltag.org" >Elanco Animal Health Incorporated</span> (NYSE: ELAN) today announced the on-time completion of a 25,000-square-foot manufacturing expansion of its <location value="LU/us.ks.elwood" idsrc="xmltag.org" >Elwood, Kansas</location> manufacturing site. As one of only two animal health companies with mAb solutions on the market today, the expansion further strengthens Elanco's leadership in the biologics space.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Elanco+Scales+Biologics+Capabilities+with+Expansion+of+Kansas+Manufacturing+Facility/26977733.html Wed, 26 Aug 2026 08:30:00 -0400 A.02928975 ELAN O.10590994 O.20972655 http://www.streetinsider.com/Press+Releases/Elanco+Scales+Biologics+Capabilities+with+Expansion+of+Kansas+Manufacturing+Facility/26977733.html <div class="xn-content"> <p class="prntac"><b><i>The completed 25,000-square-foot <location value="LU/us.ks.elwood" idsrc="xmltag.org" >Elwood</location> site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipeline</i></b></p><p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>Aug. 26, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:ELAN" idsrc="xmltag.org" >Elanco Animal Health Incorporated</span> (NYSE: ELAN) today announced the on-time completion of a 25,000-square-foot manufacturing expansion of its <location value="LU/us.ks.elwood" idsrc="xmltag.org" >Elwood, Kansas</location> manufacturing site. As one of only two animal health companies with mAb solutions on the market today, the expansion further strengthens Elanco's leadership in the biologics space.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Elanco+Scales+Biologics+Capabilities+with+Expansion+of+Kansas+Manufacturing+Facility/26977733.html Wed, 26 Aug 2026 08:30:00 -0400 A.02928975 ELAN O.10590994 O.20972655 http://www.streetinsider.com/Press+Releases/Elanco+Scales+Biologics+Capabilities+with+Expansion+of+Kansas+Manufacturing+Facility/26977733.html <div class="xn-content"> <p class="prntac"><b><i>The completed 25,000-square-foot <location value="LU/us.ks.elwood" idsrc="xmltag.org" >Elwood</location> site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipeline</i></b></p><p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>Aug. 26, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:ELAN" idsrc="xmltag.org" >Elanco Animal Health Incorporated</span> (NYSE: ELAN) today announced the on-time completion of a 25,000-square-foot manufacturing expansion of its <location value="LU/us.ks.elwood" idsrc="xmltag.org" >Elwood, Kansas</location> manufacturing site. As one of only two animal health companies with mAb solutions on the market today, the expansion further strengthens Elanco's leadership in the biologics space.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Elanco+Scales+Biologics+Capabilities+with+Expansion+of+Kansas+Manufacturing+Facility/26977733.html Wed, 26 Aug 2026 08:30:00 -0400 A.02928975 ELAN O.10590994 O.20972655 http://www.streetinsider.com/Press+Releases/Elanco+Scales+Biologics+Capabilities+with+Expansion+of+Kansas+Manufacturing+Facility/26977733.html <div class="xn-content"> <p class="prntac"><b><i>The completed 25,000-square-foot <location value="LU/us.ks.elwood" idsrc="xmltag.org" >Elwood</location> site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipeline</i></b></p><p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>Aug. 26, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:ELAN" idsrc="xmltag.org" >Elanco Animal Health Incorporated</span> (NYSE: ELAN) today announced the on-time completion of a 25,000-square-foot manufacturing expansion of its <location value="LU/us.ks.elwood" idsrc="xmltag.org" >Elwood, Kansas</location> manufacturing site. As one of only two animal health companies with mAb solutions on the market today, the expansion further strengthens Elanco's leadership in the biologics space.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Elanco+Scales+Biologics+Capabilities+with+Expansion+of+Kansas+Manufacturing+Facility/26977733.html Wed, 26 Aug 2026 08:30:00 -0400 A.02928975 ELAN O.10590994 O.20972655 http://www.streetinsider.com/PRNewswire/Elanco+Scales+Biologics+Capabilities+with+Expansion+of+Kansas+Manufacturing+Facility/26977733.html <div class="xn-content"> <p class="prntac"><b><i>The completed 25,000-square-foot <location value="LU/us.ks.elwood" idsrc="xmltag.org" >Elwood</location> site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipeline</i></b></p><p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>Aug. 26, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:ELAN" idsrc="xmltag.org" >Elanco Animal Health Incorporated</span> (NYSE: ELAN) today announced the on-time completion of a 25,000-square-foot manufacturing expansion of its <location value="LU/us.ks.elwood" idsrc="xmltag.org" >Elwood, Kansas</location> manufacturing site. As one of only two animal health companies with mAb solutions on the market today, the expansion further strengthens Elanco's leadership in the biologics space.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Elanco+Scales+Biologics+Capabilities+with+Expansion+of+Kansas+Manufacturing+Facility/26977733.html Wed, 26 Aug 2026 08:30:00 -0400 A.02928975 ELAN O.10590994 O.20972655 http://www.streetinsider.com/PRNewswire/Elanco+Scales+Biologics+Capabilities+with+Expansion+of+Kansas+Manufacturing+Facility/26977733.html <div class="xn-content"> <p class="prntac"><b><i>The completed 25,000-square-foot <location value="LU/us.ks.elwood" idsrc="xmltag.org" >Elwood</location> site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipeline</i></b></p><p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>Aug. 26, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:ELAN" idsrc="xmltag.org" >Elanco Animal Health Incorporated</span> (NYSE: ELAN) today announced the on-time completion of a 25,000-square-foot manufacturing expansion of its <location value="LU/us.ks.elwood" idsrc="xmltag.org" >Elwood, Kansas</location> manufacturing site. As one of only two animal health companies with mAb solutions on the market today, the expansion further strengthens Elanco's leadership in the biologics space.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Elanco+Scales+Biologics+Capabilities+with+Expansion+of+Kansas+Manufacturing+Facility/26977733.html Wed, 26 Aug 2026 08:30:00 -0400 A.02928975 ELAN O.10590994 O.20972655 http://www.streetinsider.com/PRNewswire/Elanco+Scales+Biologics+Capabilities+with+Expansion+of+Kansas+Manufacturing+Facility/26977733.html <div class="xn-content"> <p class="prntac"><b><i>The completed 25,000-square-foot <location value="LU/us.ks.elwood" idsrc="xmltag.org" >Elwood</location> site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipeline</i></b></p><p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>Aug. 26, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:ELAN" idsrc="xmltag.org" >Elanco Animal Health Incorporated</span> (NYSE: ELAN) today announced the on-time completion of a 25,000-square-foot manufacturing expansion of its <location value="LU/us.ks.elwood" idsrc="xmltag.org" >Elwood, Kansas</location> manufacturing site. As one of only two animal health companies with mAb solutions on the market today, the expansion further strengthens Elanco's leadership in the biologics space.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Elanco+Scales+Biologics+Capabilities+with+Expansion+of+Kansas+Manufacturing+Facility/26977733.html Wed, 26 Aug 2026 08:30:00 -0400 A.02928975 ELAN O.10590994 O.20972655 http://www.streetinsider.com/PRNewswire/Elanco+Scales+Biologics+Capabilities+with+Expansion+of+Kansas+Manufacturing+Facility/26977733.html <div class="xn-content"> <p class="prntac"><b><i>The completed 25,000-square-foot <location value="LU/us.ks.elwood" idsrc="xmltag.org" >Elwood</location> site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipeline</i></b></p><p><span class="legendSpanClass"><location value="LU/us.in.indpol" idsrc="xmltag.org" >INDIANAPOLIS</location></span>, <span class="legendSpanClass"><chron>Aug. 26, 2026</chron></span> /PRNewswire/ -- <span value="NYSE:ELAN" idsrc="xmltag.org" >Elanco Animal Health Incorporated</span> (NYSE: ELAN) today announced the on-time completion of a 25,000-square-foot manufacturing expansion of its <location value="LU/us.ks.elwood" idsrc="xmltag.org" >Elwood, Kansas</location> manufacturing site. As one of only two animal health companies with mAb solutions on the market today, the expansion further strengthens Elanco's leadership in the biologics space.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Elanco+Scales+Biologics+Capabilities+with+Expansion+of+Kansas+Manufacturing+Facility/26977733.html Wed, 26 Aug 2026 08:30:00 -0400 A.02928975 ELAN O.10590994 O.20972655 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+21++Filed+by%3A+Modi+Rajeev+A./26975320.html si-local-file:///var/storage/secattach/20260825/26975320.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+21++Filed+by%3A+Modi+Rajeev+A./26975320.html Tue, 25 Aug 2026 16:43:00 -0400 ELAN O.10590994 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+21++Filed+by%3A+Modi+Rajeev+A./26975320.html si-local-file:///var/storage/secattach/20260825/26975320.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+21++Filed+by%3A+Modi+Rajeev+A./26975320.html Tue, 25 Aug 2026 16:43:00 -0400 ELAN O.10590994 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+21++Filed+by%3A+VanHimbergen+Robert+M/26975312.html si-local-file:///var/storage/secattach/20260825/26975312.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+21++Filed+by%3A+VanHimbergen+Robert+M/26975312.html Tue, 25 Aug 2026 16:42:00 -0400 ELAN O.10590994 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+21++Filed+by%3A+VanHimbergen+Robert+M/26975312.html si-local-file:///var/storage/secattach/20260825/26975312.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+21++Filed+by%3A+VanHimbergen+Robert+M/26975312.html Tue, 25 Aug 2026 16:42:00 -0400 ELAN O.10590994 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+21++Filed+by%3A+Simmons+Jeffrey+N/26975299.html si-local-file:///var/storage/secattach/20260825/26975299.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+21++Filed+by%3A+Simmons+Jeffrey+N/26975299.html Tue, 25 Aug 2026 16:41:00 -0400 ELAN O.10590994 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+21++Filed+by%3A+Simmons+Jeffrey+N/26975299.html si-local-file:///var/storage/secattach/20260825/26975299.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+21++Filed+by%3A+Simmons+Jeffrey+N/26975299.html Tue, 25 Aug 2026 16:41:00 -0400 ELAN O.10590994 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+20++Filed+by%3A+Kurzius+Lawrence+Erik/26961624.html si-local-file:///var/storage/secattach/20260821/26961624.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+20++Filed+by%3A+Kurzius+Lawrence+Erik/26961624.html Fri, 21 Aug 2026 16:17:00 -0400 ELAN O.10590994 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+20++Filed+by%3A+Kurzius+Lawrence+Erik/26961624.html si-local-file:///var/storage/secattach/20260821/26961624.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+20++Filed+by%3A+Kurzius+Lawrence+Erik/26961624.html Fri, 21 Aug 2026 16:17:00 -0400 ELAN O.10590994 http://www.streetinsider.com/Analyst+Comments/Elanco+Animal+Health+%28ELAN%29+Reiterated+at+Buy+by+Stifel+as+Rebate+Activity+Accelerates/26953315.html <p>Stifel analyst Jonathan Block reiterated a Buy rating and $33.00 price target on Elanco Animal Health (NYSE: ELAN).</p><p>The analyst commented, "Rebate activity has accelerated, but this is netted against revenue, and Pet Health sales growth is accelerating. There is skepticism Elanco can meet its 2H26 U.S. Pet Health revenue growth goals (+HSD-LDD%) considering what is viewed as a tepid market and an increasingly competitive market backdrop. Elanco’s ability to deliver on this metric (along with margin expansion) may be the key to 2H26 stock performance."</p><p>For an analyst ratings summary and ratings history on Elanco Animal Health <a href="http://www.streetinsider.com/rating_history.php?q=ELAN">click here</a>. For http://www.streetinsider.com/Analyst+Comments/Elanco+Animal+Health+%28ELAN%29+Reiterated+at+Buy+by+Stifel+as+Rebate+Activity+Accelerates/26953315.html Thu, 20 Aug 2026 08:10:17 -0400 ELAN http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+18++Filed+by%3A+O%26apos%3BNeill+Shiv/26944830.html si-local-file:///var/storage/secattach/20260818/26944830.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+18++Filed+by%3A+O%26apos%3BNeill+Shiv/26944830.html Tue, 18 Aug 2026 16:32:00 -0400 ELAN O.10590994 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+18++Filed+by%3A+O%26apos%3BNeill+Shiv/26944830.html si-local-file:///var/storage/secattach/20260818/26944830.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+18++Filed+by%3A+O%26apos%3BNeill+Shiv/26944830.html Tue, 18 Aug 2026 16:32:00 -0400 ELAN O.10590994 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+12++Filed+by%3A+Harrington+Michael+J/26921751.html si-local-file:///var/storage/secattach/20260813/26921751.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+12++Filed+by%3A+Harrington+Michael+J/26921751.html Thu, 13 Aug 2026 16:29:00 -0400 ELAN O.10590994 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+12++Filed+by%3A+Harrington+Michael+J/26921751.html si-local-file:///var/storage/secattach/20260813/26921751.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Elanco+Animal+Health++++++For%3A+Aug+12++Filed+by%3A+Harrington+Michael+J/26921751.html Thu, 13 Aug 2026 16:29:00 -0400 ELAN O.10590994 http://www.streetinsider.com/Corporate+News/FDA+grants+Elanco+emergency+authorization+for+screwworm+wound+spray/26903372.html <p>Elanco Animal Health Incorporated (NYSE: ELAN) has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its CLiK Extra (dicyclanil topical suspension) wound spray to prevent New World screwworm infestations in a range of livestock and wildlife species.</p><p>The authorization covers use of CLiK Extra on or around wounds in sheep, cattle, goats, swine, and camelids, as well as captive and captured cervids, American bison, bighorn sheep, and Sonoran pronghorn. The product is intended to prevent infestations of New World screwworm larvae before they occur, including wounds associated with birth and surgical procedures.</p><p>CLiK Extra has not been http://www.streetinsider.com/Corporate+News/FDA+grants+Elanco+emergency+authorization+for+screwworm+wound+spray/26903372.html Tue, 11 Aug 2026 10:26:29 -0400 ELAN